RGLS continues pivoting around that 618 Fib line. Overall, it has held a clear uptrend despite the pullback. Trend line lines up almost perfectly with the latest higher lows put in. RNA companies remain a focus. In this case, it's not covid but kidney diseases. "In mid-May, Regulus Therapeutics announced an incremental update of its autosomal dominant...
Started buying in the handle, I feel breakout will happen next week. Price target on pattern 3.61. Overall price target is 5.00. There is bull flag forming on the handle.
RGLS forming a nice fallen angel formation. IT has significant insider buying. It has few moving average to overcome however it has very good upside potential as it is coming down from huge £20 area. To play this we would consider February 2018 $2.50 Calls, currently $0.08 * Trade Criteria * Date First Found- August 24, 2017 (Intraday Alert) Pattern/Why-...
RGLS is gone to the downside with a huge gap and run. After the bounce it is in the middle of a correction. I'm expecting a breakout to the upside to test the downward trendline and to fill the gap.